Updated on 15 June 2026
PHARMORIS - governed medicines action layer
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
About
PHARMORIS is a staff-facing medicines action, evidence and governance platform for healthcare organisations.
It helps teams move from medicines signals into governed ActionCases, evidence packs, source traceability, human review, approval/gate workflows, stakeholder acknowledgement, blocker tracking, value review and audit trails.
The product is not autonomous prescribing, not a prescribing engine and not a replacement for pharmacists, clinicians, finance, procurement or governance judgement.
The current focus is controlled pilot-readiness: making the route from signal to decision to deployment more transparent, evidence-led and accountable.
PHARMORIS is especially relevant to people working on medicines optimisation, NHS innovation, regulatory science, standards, AI assurance, clinical safety, evidence generation, healthtech commercialisation and public-interest digital infrastructure.
I’m interested in practical conversations on what evidence matters, what buyers trust, what risks must be controlled, and what turns health innovation into safe adoption.
Looking for
- Buyer
- Re-Seller/Wholesaler
- License partner
- Investment/Finance
Organisation
Similar opportunities
Investment
PHARMORIS £1.4m seed round - evidence-led medicines workflow platform
- Series A | Scale business
- Seed funding | Get business started
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Project cooperation
PHARMORIS pilot-readiness cooperation: evidence, standards and NHS adoption
- Market Access
- Strategic Partnership
- Dissemination project results
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Expertise
Evidence-led healthtech, medicines workflow and pilot-readiness
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom